This compound is a salt form of a benozazepine-based primary amine, typically supplied as a pharmaceutical intermediate. Its structure consists of a tricyclic amine core and a fumaric acid counterion, indicating use in research or manufacturing settings.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 127785-96-0
6-Aminomethyl-6,11-dihydro-5H-dibenz[b,e]azepine (E)-2-butenedioate
Intermediate for epinastine hydrochloride
(alphaR)-alpha-Methyl-3,5-bis(trifluoromethyl)benzenemethanol
Pharmaceutical intermediate
(3S)-4-chloro-3-hydroxybutanenitrile
chiral pharmaceutical intermediate
(2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
Empagliflozin intermediate
Ethyl 3-(nitromethyl)hexanoate
pharmaceutical intermediate
(E)-but-2-enedioic acid;6,11-dihydro-5H-benzo[c][1]benzazepin-6-ylmethanamine
IUQYGXGUFNMQGL-WLHGVMLRSA-N
C1C2=CC=CC=C2C(NC3=CC=CC=C31)CN.C(=C/C(=O)O)\C(=O)O
—